NDC 0268-0041 Center-al - Betula Lenta Pollen

Betula Lenta Pollen Injection, Suspension Subcutaneous - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
0268-0041
Proprietary Name:
Center-al - Betula Lenta Pollen
Non-Proprietary Name: [1]
Betula Lenta Pollen
Substance Name: [2]
Betula Lenta Pollen
NDC Directory Status:
Non-standardized Allergenic
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
Administration Route(s): [4]
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Labeler Name: [5]
    Alk-abello, Inc.
    Labeler Code:
    0268
    FDA Application Number: [6]
    BLA103753
    Marketing Category: [8]
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date: [9]
    01-15-1975
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 0268-0041-10

    Package Description: 10 mL in 1 VIAL, MULTI-DOSE

    NDC Code 0268-0041-30

    Package Description: 30 mL in 1 VIAL, MULTI-DOSE

    Product Details

    What is NDC 0268-0041?

    The NDC code 0268-0041 is assigned by the FDA to the product Center-al - Betula Lenta Pollen which is a non-standardized allergenic label product labeled by Alk-abello, Inc.. The generic name of Center-al - Betula Lenta Pollen is betula lenta pollen. The product's dosage form is injection, suspension and is administered via subcutaneous form. The product is distributed in 2 packages with assigned NDC codes 0268-0041-10 10 ml in 1 vial, multi-dose , 0268-0041-30 30 ml in 1 vial, multi-dose . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Center-al - Betula Lenta Pollen?

    Hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. Prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient's history confirmed by diagnostic skin testing. Hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided.

    What are Center-al - Betula Lenta Pollen Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    Which are Center-al - Betula Lenta Pollen UNII Codes?

    The UNII codes for the active ingredients in this product are:

    • ACACIA LONGIFOLIA POLLEN (UNII: 24SO2J296O)
    • ACACIA LONGIFOLIA POLLEN (UNII: 24SO2J296O) (Active Moiety)
    • ALNUS INCANA SUBSP. RUGOSA POLLEN (UNII: 605T96G8Y5)
    • ALNUS INCANA SUBSP. RUGOSA POLLEN (UNII: 605T96G8Y5) (Active Moiety)
    • FRAXINUS AMERICANA POLLEN (UNII: G684LX721Q)
    • FRAXINUS AMERICANA POLLEN (UNII: G684LX721Q) (Active Moiety)
    • PASPALUM NOTATUM POLLEN (UNII: V003SHB7VK)
    • PASPALUM NOTATUM POLLEN (UNII: V003SHB7VK) (Active Moiety)
    • FAGUS GRANDIFOLIA POLLEN (UNII: 34X886W1H4)
    • FAGUS GRANDIFOLIA POLLEN (UNII: 34X886W1H4) (Active Moiety)
    • CYNODON DACTYLON POLLEN (UNII: 175F461W10)
    • CYNODON DACTYLON POLLEN (UNII: 175F461W10) (Active Moiety)
    • BETULA LENTA POLLEN (UNII: JQ5HI5004M)
    • BETULA LENTA POLLEN (UNII: JQ5HI5004M) (Active Moiety)

    Which are Center-al - Betula Lenta Pollen Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Center-al - Betula Lenta Pollen?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
    • RxCUI: 1095410 - annual bluegrass pollen extract 20000 UNT/ML Injectable Suspension
    • RxCUI: 1095410 - annual bluegrass pollen extract 20,000 UNT/ML Injectable Suspension
    • RxCUI: 1115843 - rough cocklebur pollen extract 5000 UNT/mL Injectable Suspension
    • RxCUI: 1115843 - rough cocklebur pollen extract 5000 UNT/ML Injectable Suspension
    • RxCUI: 1115843 - Xanthium strumarium pollen extract 5000 UNT/ML Injectable Suspension

    Which are the Pharmacologic Classes for Center-al - Betula Lenta Pollen?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".